DEPO-PROVERA 150 MG/ML SYRINGE

What it is

DEPO-PROVERA 150 MG/ML SYRINGE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as medroxyprogesterone acetate, under the trade name “Depo-Provera”.

FDA gives its dosage form as injection, suspension and its route as intramuscular.

The labeler, the company named on the label, is Pharmacia & Upjohn Company LLC.

FDA’s Established Pharmacologic Class for it is Progestin.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00009-7376-11.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $52.34 for 1 mL (1 × $52.335 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $27.36384 per ML filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What NADAC measures · NADAC explanation codes

The NDC

• 00009-7376-11 · Pharmacia & Upjohn Company LLC · $52.335 per ML · eff. 2026-09-23 filed

Other strengths, forms and brands

6 other products in the NADAC file share the FDA nonproprietary name medroxyprogesterone acetate with DEPO-PROVERA 150 MG/ML SYRINGE.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-04-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $52.335 per ML filed.

Of the 5 other products in FDA’s Progestin class priced per ML, 1 has a higher middle NADAC price and 4 a lower one. The one in the middle is MEDROXYPROGESTERONE 150 MG/ML, at $22.84953 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $56.81 for 1 mL, at an average of $56.80944 per ML in 2024 (2024-01-01 to 2024-12-31) for “Depo-Provera” and “Medroxyprogesterone Acetate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 178 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 1 mL? Is it lower than what I would pay through my insurance?
• How much is in the package I am getting? This page uses 1 mL; your package may hold a different amount.
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.